China Feihe Limited (6186.HK)
Sells infant formula and nutritional supplements across China and internationally.
3.38+0.03%Consumer Defensive
StockGlow Score
Neutral
BearishBullish
1 year ago-26.2%
The outlook
China Feihe is trading near the lower end of its 52-week range, with the average analyst target sitting roughly 27% above the current price. Analyst consensus leans toward Buy, though the stock's price movement relative to its moving averages shows mixed momentum. The valuation appears modest at 14.1 trailing P/E.
What’s behind the score
Analyst consensusBuy — 2.2 avg of 14 analysts
Price trendMixed vs its moving averages
52-week range26% of the way from its 52-week low to high
Price targetAvg target +27% vs current price
Analyst price target
~12-month · 14 analysts4.30average target+27.3% vs now
Now 3.38
Low 3.44High 5.41
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$29.77B
52-wk high
5.08
52-wk low
2.79
50-day avg
3.09
200-day avg
3.69
Trailing P/E
14.1